The Lupus Research Alliance (LRA) has announced grants totalling more than $2 million to support clinical research into lifestyle interventions for people living with lupus. The awards, made under the charity's 2026 Mechanistic Clinical Award programme, will fund pilot studies exploring targeted, low‑risk approaches — including dietary supplements, physical activity and online whole‑health programmes — that could be used alongside conventional treatments.
Putting lifestyle on the research agenda
Lupus is a chronic autoimmune condition that affects millions globally and can vary hugely between individuals in symptoms, severity and response to therapy. While new targeted treatments have improved outcomes for some patients, many still contend with persistent fatigue, fluctuating disease activity, medication side‑effects and long‑term organ damage. The LRA said those realities emphasise the need for complementary strategies that might enhance quality of life without adding significant risks.
"Lifestyle interventions hold great promise for improving outcomes in lupus, but research in this area remains chronically underfunded," said Kari Fischer, PhD, Scientific Programme Officer at the Lupus Research Alliance.
The Mechanistic Clinical Award stream is designed to underwrite innovative pilot studies that examine not only whether an approach works, but how it produces biological effects — a step intended to accelerate precision medicine. This year the programme specifically prioritised lifestyle‑focused projects.
What the funding will support
Following a competitive review, three projects were selected to receive support. Each award can provide up to $750,000 over three years, allowing small, nimble clinical studies to generate early mechanistic evidence that could justify larger trials.
- Funding pool: more than $2 million across the 2026 awards.
- Award size: up to $750,000 per recipient, over three years.
- Focus: lifestyle interventions such as ginger supplementation, physical activity interventions and a whole‑health online programme.
One named recipient is Dr Jason Knight of the Regents of the University of Michigan, whose work relates to the role of neutrophils — a type of white blood cell — in driving inflammation. The announcement indicates that selected research will look to link lifestyle approaches with underlying biological pathways, though details of each study were not provided in full in the LRA release.
Why this matters
Researchers and patient groups have long called for more rigorous study of non‑pharmacological approaches in autoimmune conditions. Lifestyle measures often appeal because they can be implemented with low incremental risk and may address persistent symptoms such as fatigue and impaired wellbeing that are not always resolved by medication alone. However, without robust mechanistic and clinical trial data, clinicians lack guidance on which interventions are effective and how to integrate them into routine care.
By funding mechanistic pilot trials, the LRA aims to build an evidence base that could inform larger, definitive studies and, ultimately, clinical recommendations. The charity framed the awards as part of a wider commitment to exploring every plausible avenue to improve outcomes for people affected by lupus.
| Programme | Maximum award | Duration |
|---|---|---|
| 2026 Mechanistic Clinical Award | $750,000 per recipient | Up to 3 years |
| Total announced funding | More than $2,000,000 | — |
For people living with lupus, the new grants represent a potential step towards interventions that could be added to conventional care to improve day‑to‑day wellbeing. For researchers, the awards provide resources to explore how modifications to diet, activity and holistic health support might change inflammatory processes and clinical outcomes. The LRA said the approach is intended to accelerate progress towards personalised strategies that complement existing therapies.
Further information on the individual studies and outcomes will be made available as the projects progress and publish results.
